Finance Watch: CF Foundation Commits $110m In Partnership With Flagship’s Pioneering Medicines
Service Providers lead $1.75bn In VC Mega-Rounds
Private Company Edition: Flagship’s Pioneering Medicines initiative and the firm’s portfolio companies will deliver cystic fibrosis drug candidates. Also, recent venture capital financings include cloud technology firm Saama’s $430m round and Shoreline’s $140m in new funding.
